| Symbol | Description |
| AATF | Apoptosis antagonizing transcription factor |
| ABL1 | V-abl Abelson murine leukemia viral oncogene homolog 1 |
| ACCN1 | Amiloride-sensitive cation channel 1, neuronal (degenerin) |
| ACIN1 | Apoptotic chromatin condensation inducer 1 |
| ACTC1 | Actin, alpha, cardiac muscle 1 |
| ACTN1 | Actinin, alpha 1 |
| ACTN2 | Actinin, alpha 2 |
| ACTN3 | Actinin, alpha 3 |
| ACTN4 | Actinin, alpha 4 |
| ACVR1 | Activin A receptor, type I |
| ACVR1B | Activin A receptor, type IB |
| ACVR1C | Activin A receptor, type IC |
| ADAMTSL4 | ADAMTS-like 4 |
| ADORA1 | Adenosine A1 receptor |
| ADORA2A | Adenosine A2a receptor |
| ADRA1A | Adrenergic, alpha-1A-, receptor |
| AGT | Angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
| AGTR2 | Angiotensin II receptor, type 2 |
| AHR | Aryl hydrocarbon receptor |
| AIFM1 | Apoptosis-inducing factor, mitochondrion-associated, 1 |
| AIFM2 | Apoptosis-inducing factor, mitochondrion-associated, 2 |
| AIFM3 | Apoptosis-inducing factor, mitochondrion-associated, 3 |
| AKT1 | V-akt murine thymoma viral oncogene homolog 1 |
| AKT1S1 | AKT1 substrate 1 (proline-rich) |
| AKTIP | AKT interacting protein |
| ALB | Albumin |
| ALOX12 | Arachidonate 12-lipoxygenase |
| ALOX15B | Arachidonate 15-lipoxygenase, type B |
| ALS2CR2 | Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 2 |
| ANGPTL4 | Angiopoietin-like 4 |
| ANXA1 | Annexin A1 |
| ANXA4 | Annexin A4 |
| ANXA5 | Annexin A5 |
| APAF1 | Apoptotic peptidase activating factor 1 |
| APBB2 | Amyloid beta (A4) precursor protein-binding, family B, member 2 (Fe65-like) |
| API5 | Apoptosis inhibitor 5 |
| APIP | APAF1 interacting protein |
| APLP1 | Amyloid beta (A4) precursor-like protein 1 |
| APOE | Apolipoprotein E |
| APP | Amyloid beta (A4) precursor protein (peptidase nexin-II, Alzheimer disease) |
| APPBP1 | Amyloid beta precursor protein binding protein 1 |
| 2-Apr | Chromosome 17 open reading frame 88 |
| ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha |
| ARHGEF6 | Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
| ASAH2 | N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2 |
| ATF5 | Activating transcription factor 5 |
| ATG12 | ATG12 autophagy related 12 homolog (S. cerevisiae) |
| ATG5 | ATG5 autophagy related 5 homolog (S. cerevisiae) |
| ATOH1 | Atonal homolog 1 (Drosophila) |
| AVEN | Apoptosis, caspase activation inhibitor |
| AXIN1 | Axin 1 |
| AXUD1 | AXIN1 up-regulated 1 |
| AZU1 | Azurocidin 1 (cationic antimicrobial protein 37) |
| B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
| BAD | BCL2-antagonist of cell death |
| BAG1 | BCL2-associated athanogene |
| BAG2 | BCL2-associated athanogene 2 |
| BAG3 | BCL2-associated athanogene 3 |
| BAG4 | BCL2-associated athanogene 4 |
| BAG5 | BCL2-associated athanogene 5 |
| BAK1 | BCL2-antagonist/killer 1 |
| BAPX1 | NK3 homeobox 2 |
| BARD1 | BRCA1 associated RING domain 1 |
| BAX | BCL2-associated X protein |
| BBC3 | BCL2 binding component 3 |
| BCAP29 | B-cell receptor-associated protein 29 |
| BCAP31 | B-cell receptor-associated protein 31 |
| BCL10 | B-cell CLL/lymphoma 10 |
| BCL2 | B-cell CLL/lymphoma 2 |
| BCL2A1 | BCL2-related protein A1 |
| BCL2L1 | BCL2-like 1 |
| BCL2L10 | BCL2-like 10 (apoptosis facilitator) |
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) |
| BCL2L12 | BCL2-like 12 (proline rich) |
| BCL2L13 | BCL2-like 13 (apoptosis facilitator) |
| BCL2L14 | BCL2-like 14 (apoptosis facilitator) |
| BCL2L2 | BCL2-like 2 |
| BCL3 | B-cell CLL/lymphoma 3 |
| BCL6 | B-cell CLL/lymphoma 6 (zinc finger protein 51) |
| BCL7C | B-cell CLL/lymphoma 7C |
| BCLAF1 | BCL2-associated transcription factor 1 |
| BDNF | Brain-derived neurotrophic factor |
| BECN1 | Beclin 1 (coiled-coil, myosin-like BCL2 interacting protein) |
| BFAR | Bifunctional apoptosis regulator |
| BID | BH3 interacting domain death agonist |
| BIK | BCL2-interacting killer (apoptosis-inducing) |
| BIRC2 | Baculoviral IAP repeat-containing 2 |
| BIRC3 | Baculoviral IAP repeat-containing 3 |
| BIRC4 | Baculoviral IAP repeat-containing 4 |
| BIRC6 | Baculoviral IAP repeat-containing 6 (apollon) |
| BIRC7 | Baculoviral IAP repeat-containing 7 (livin) |
| BIRC8 | Baculoviral IAP repeat-containing 8 |
| BLID | BH3-like motif containing, cell death inducer |
| BMF | Bcl2 modifying factor |
| BNIP1 | BCL2/adenovirus E1B 19kDa interacting protein 1 |
| BNIP2 | BCL2/adenovirus E1B 19kDa interacting protein 2 |
| BNIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 |
| BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like |
| BNIPL | BCL2/adenovirus E1B 19kD interacting protein like |
| BOK | BCL2-related ovarian killer |
| BRAF | V-raf murine sarcoma viral oncogene homolog B1 |
| BRCA1 | Breast cancer 1, early onset |
| BRE | Brain and reproductive organ-expressed (TNFRSF1A modulator) |
| BTG1 | B-cell translocation gene 1, anti-proliferative |
| BTK | Bruton agammaglobulinemia tyrosine kinase |
| BUB1B | BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast) |
| C10orf61 | Chromosome 10 open reading frame 61 |
| C3orf38 | Chromosome 3 open reading frame 38 |
| C8orf4 | Chromosome 8 open reading frame 4 |
| CADM1 | Cell adhesion molecule 1 |
| CALR | Calreticulin |
| CARD10 | Caspase recruitment domain family, member 10 |
| CARD11 | Caspase recruitment domain family, member 11 |
| CARD14 | Caspase recruitment domain family, member 14 |
| CARD6 | Caspase recruitment domain family, member 6 |
| CARD8 | Caspase recruitment domain family, member 8 |
| CARD9 | Caspase recruitment domain family, member 9 |
| CASP1 | Caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) |
| CASP10 | Caspase 10, apoptosis-related cysteine peptidase |
| CASP12 | Caspase 12 |
| CASP14 | Caspase 14, apoptosis-related cysteine peptidase |
| CASP2 | Caspase 2, apoptosis-related cysteine peptidase (neural precursor cell expressed, developmentally down-regulated 2) |
| CASP3 | Caspase 3, apoptosis-related cysteine peptidase |
| CASP4 | Caspase 4, apoptosis-related cysteine peptidase |
| CASP5 | Caspase 5, apoptosis-related cysteine peptidase |
| CASP6 | Caspase 6, apoptosis-related cysteine peptidase |
| CASP7 | Caspase 7, apoptosis-related cysteine peptidase |
| CASP8 | Caspase 8, apoptosis-related cysteine peptidase |
| CASP8AP2 | CASP8 associated protein 2 |
| CASP9 | Caspase 9, apoptosis-related cysteine peptidase |
| CBX4 | Chromobox homolog 4 (Pc class homolog, Drosophila) |
| CCAR1 | Cell division cycle and apoptosis regulator 1 |
| CCL2 | Chemokine (C-C motif) ligand 2 |
| CD14 | CD14 molecule |
| CD2 | CD2 molecule |
| CD27 | CD27 molecule |
| CD28 | CD28 molecule |
| CD38 | CD38 molecule |
| CD3E | CD3e molecule, epsilon (CD3-TCR complex) |
| CD3G | CD3g molecule, gamma (CD3-TCR complex) |
| CD40 | CD40 molecule, TNF receptor superfamily member 5 |
| CD40LG | CD40 ligand (TNF superfamily, member 5, hyper-IgM syndrome) |
| CD5 | CD5 molecule |
| CD5L | CD5 molecule-like |
| CD70 | CD70 molecule |
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain |
| CDC2 | Cell division cycle 2, G1 to S and G2 to M |
| CDC2L2 | Cell division cycle 2-like 2 (PITSLRE proteins) |
| CDK5 | Cyclin-dependent kinase 5 |
| CDK5R1 | Cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
| CDKN1A | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
| CDKN2A | Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) |
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta |
| CEBPG | CCAAT/enhancer binding protein (C/EBP), gamma |
| CECR2 | Cat eye syndrome chromosome region, candidate 2 |
| CFDP1 | Craniofacial development protein 1 |
| CFL1 | Cofilin 1 (non-muscle) |
| CFLAR | CASP8 and FADD-like apoptosis regulator |
| CGB | Chorionic gonadotropin, beta polypeptide |
| CGB5 | Chorionic gonadotropin, beta polypeptide 5 |
| CGB7 | Chorionic gonadotropin, beta polypeptide 7 |
| CGB8 | Chorionic gonadotropin, beta polypeptide 8 |
| CHEK2 | CHK2 checkpoint homolog (S. pombe) |
| CIAPIN1 | Cytokine induced apoptosis inhibitor 1 |
| CIB1 | Calcium and integrin binding 1 (calmyrin) |
| CIDEB | Cell death-inducing DFFA-like effector b |
| CIDEC | Cell death-inducing DFFA-like effector c |
| CKAP2 | Cytoskeleton associated protein 2 |
| CLCF1 | Cardiotrophin-like cytokine factor 1 |
| CLN3 | Ceroid-lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
| CLU | Clusterin |
| COL18A1 | Collagen, type XVIII, alpha 1 |
| COL4A3 | Collagen, type IV, alpha 3 (Goodpasture antigen) |
| COP1 | Caspase-1 dominant-negative inhibitor pseudo-ICE |
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain |
| CROP | Cisplatin resistance-associated overexpressed protein |
| CRTAM | Cytotoxic and regulatory T cell molecule |
| CRYAA | Crystallin, alpha A |
| CRYAB | Crystallin, alpha B |
| CSE1L | CSE1 chromosome segregation 1-like (yeast) |
| CSF2 | Colony stimulating factor 2 (granulocyte-macrophage) |
| CTNNAL1 | Catenin (cadherin-associated protein), alpha-like 1 |
| CTNNBL1 | Catenin, beta like 1 |
| CTSB | Cathepsin B |
| CUL1 | Cullin 1 |
| CUL2 | Cullin 2 |
| CUL3 | Cullin 3 |
| CUL4A | Cullin 4A |
| CUL5 | Cullin 5 |
| CXCR4 | Chemokine (C-X-C motif) receptor 4 |
| CYCS | Cytochrome c, somatic |
| CYFIP2 | Cytoplasmic FMR1 interacting protein 2 |
| DAD1 | Defender against cell death 1 |
| DAP | Death-associated protein |
| DAP3 | Death associated protein 3 |
| DAPK1 | Death-associated protein kinase 1 |
| DAPK2 | Death-associated protein kinase 2 |
| DAPK3 | Death-associated protein kinase 3 |
| DAXX | Death-associated protein 6 |
| DCC | Deleted in colorectal carcinoma |
| DDAH2 | Dimethylarginine dimethylaminohydrolase 2 |
| DDIT3 | DNA-damage-inducible transcript 3 |
| DDX20 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 |
| DDX41 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 41 |
| DEDD | Death effector domain containing |
| DEDD2 | Death effector domain containing 2 |
| DFFA | DNA fragmentation factor, 45kDa, alpha polypeptide |
| DFFB | DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) |
| DHCR24 | 24-dehydrocholesterol reductase |
| DIABLO | Diablo homolog (Drosophila) |
| DIDO1 | Death inducer-obliterator 1 |
| DLG5 | Discs, large homolog 5 (Drosophila) |
| DNAJA3 | DnaJ (Hsp40) homolog, subfamily A, member 3 |
| DNAJB13 | DnaJ (Hsp40) related, subfamily B, member 13 |
| DNAJB6 | DnaJ (Hsp40) homolog, subfamily B, member 6 |
| DNASE1 | Deoxyribonuclease I |
| DNASE1L3 | Deoxyribonuclease I-like 3 |
| DNASE2 | Deoxyribonuclease II, lysosomal |
| DNM1L | Dynamin 1-like |
| DNM2 | Dynamin 2 |
| DOCK1 | Dedicator of cytokinesis 1 |
| DPF1 | D4, zinc and double PHD fingers family 1 |
| DPF2 | D4, zinc and double PHD fingers family 2 |
| DRAM | Damage-regulated autophagy modulator |
| DUSP22 | Dual specificity phosphatase 22 |
| DYRK2 | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
| E2F1 | E2F transcription factor 1 |
| EAF2 | ELL associated factor 2 |
| EBAG9 | Estrogen receptor binding site associated, antigen, 9 |
| EDAR | Ectodysplasin A receptor |
| EEF1A2 | Eukaryotic translation elongation factor 1 alpha 2 |
| EEF1E1 | Eukaryotic translation elongation factor 1 epsilon 1 |
| EGLN3 | Egl nine homolog 3 (C. elegans) |
| EI24 | Etoposide induced 2.4 mRNA |
| EIF2AK2 | Eukaryotic translation initiation factor 2-alpha kinase 2 |
| EIF2AK3 | Eukaryotic translation initiation factor 2-alpha kinase 3 |
| EIF5A | Eukaryotic translation initiation factor 5A |
| ELMO1 | Engulfment and cell motility 1 |
| ELMO2 | Engulfment and cell motility 2 |
| ELMO3 | Engulfment and cell motility 3 |
| ELMOD1 | ELMO/CED-12 domain containing 1 |
| ELMOD2 | ELMO/CED-12 domain containing 2 |
| EP300 | E1A binding protein p300 |
| ERC1 | ELKS/RAB6-interacting/CAST family member 1 |
| ERCC2 | Excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D) |
| ERCC3 | Excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) |
| ERN1 | Endoplasmic reticulum to nucleus signalling 1 |
| ERN2 | Endoplasmic reticulum to nucleus signalling 2 |
| ESPL1 | Extra spindle pole bodies homolog 1 (S. cerevisiae) |
| F2 | Coagulation factor II (thrombin) |
| F2R | Coagulation factor II (thrombin) receptor |
| FADD | Fas (TNFRSF6)-associated via death domain |
| FAF1 | Fas (TNFRSF6) associated factor 1 |
| FAIM | Fas apoptotic inhibitory molecule |
| FAIM2 | Fas apoptotic inhibitory molecule 2 |
| FAIM3 | Fas apoptotic inhibitory molecule 3 |
| FAM130A1 | Family with sequence similarity 130, member A1 |
| FAM130A2 | Family with sequence similarity 130, member A2 |
| FAM82C | Family with sequence similarity 82, member C |
| FAS | Fas (TNF receptor superfamily, member 6) |
| FASLG | Fas ligand (TNF superfamily, member 6) |
| FASTK | Fas-activated serine/threonine kinase |
| FASTKD1 | FAST kinase domains 1 |
| FASTKD2 | FAST kinase domains 2 |
| FASTKD3 | FAST kinase domains 3 |
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
| FEM1B | Fem-1 homolog b (C. elegans) |
| FGF4 | Fibroblast growth factor 4 (heparin secretory transforming protein 1, Kaposi sarcoma oncogene) |
| FIS1 | Fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) |
| FKBP8 | FK506 binding protein 8, 38kDa |
| FKSG2 | Apoptosis inhibitor |
| FOXL2 | Forkhead box L2 |
| FOXO1 | Forkhead box O1 |
| FOXO3 | Forkhead box O3 |
| FXR1 | Fragile X mental retardation, autosomal homolog 1 |
| GADD45A | Growth arrest and DNA-damage-inducible, alpha |
| GADD45B | Growth arrest and DNA-damage-inducible, beta |
| GADD45G | Growth arrest and DNA-damage-inducible, gamma |
| GAS2 | Growth arrest-specific 2 |
| GCLC | Glutamate-cysteine ligase, catalytic subunit |
| GCLM | Glutamate-cysteine ligase, modifier subunit |
| GDF5 | Growth differentiation factor 5 |
| GDNF | Glial cell derived neurotrophic factor |
| GFRAL | GDNF family receptor alpha like |
| GLO1 | Glyoxalase I |
| GLRX2 | Glutaredoxin 2 |
| GML | GPI anchored molecule like protein |
| GPR65 | G protein-coupled receptor 65 |
| GPX1 | Glutathione peroxidase 1 |
| GRIK2 | Glutamate receptor, ionotropic, kainate 2 |
| GRM4 | Glutamate receptor, metabotropic 4 |
| GSK3B | Glycogen synthase kinase 3 beta |
| GSTP1 | Glutathione S-transferase pi |
| GULP1 | GULP, engulfment adaptor PTB domain containing 1 |
| GZMA | Granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
| GZMB | Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
| GZMH | Granzyme H (cathepsin G-like 2, protein h-CCPX) |
| HAND2 | Heart and neural crest derivatives expressed 2 |
| HBXIP | Hepatitis B virus x interacting protein |
| HD | Huntingtin (Huntington disease) |
| HDAC1 | Histone deacetylase 1 |
| HDAC3 | Histone deacetylase 3 |
| HIP1 | Huntingtin interacting protein 1 |
| HIPK2 | Homeodomain interacting protein kinase 2 |
| HIPK3 | Homeodomain interacting protein kinase 3 |
| HMGB1 | High-mobility group box 1 |
| HRK | Harakiri, BCL2 interacting protein (contains only BH3 domain) |
| HSP90B1 | Heat shock protein 90kDa beta (Grp94), member 1 |
| HSPA1A | Heat shock 70kDa protein 1A |
| HSPA1B | Heat shock 70kDa protein 1B |
| HSPA9 | Heat shock 70kDa protein 9 (mortalin) |
| HSPB1 | Heat shock 27kDa protein 1 |
| HSPD1 | Heat shock 60kDa protein 1 (chaperonin) |
| HSPE1 | Heat shock 10kDa protein 1 (chaperonin 10) |
| HTATIP2 | HIV-1 Tat interactive protein 2, 30kDa |
| HTRA2 | HtrA serine peptidase 2 |
| IAPP | Islet amyloid polypeptide |
| ICEBERG | ICEBERG caspase-1 inhibitor |
| IER3 | Immediate early response 3 |
| IFI6 | Interferon, alpha-inducible protein 6 |
| IFIH1 | Interferon induced with helicase C domain 1 |
| IFNA2 | Interferon, alpha 2 |
| IFNB1 | Interferon, beta 1, fibroblast |
| IFNG | Interferon, gamma |
| IFT57 | Intraflagellar transport 57 homolog (Chlamydomonas) |
| IGF1R | Insulin-like growth factor 1 receptor |
| IGFBP3 | Insulin-like growth factor binding protein 3 |
| IHPK2 | Inositol hexaphosphate kinase 2 |
| IHPK3 | Inositol hexaphosphate kinase 3 |
| IKBKG | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
| IKIP | IKK interacting protein |
| IL10 | Interleukin 10 |
| IL17A | Interleukin 17A |
| IL18 | Interleukin 18 (interferon-gamma-inducing factor) |
| IL19 | Interleukin 19 |
| IL1A | Interleukin 1, alpha |
| IL1B | Interleukin 1, beta |
| IL2 | Interleukin 2 |
| IL24 | Interleukin 24 |
| IL2RA | Interleukin 2 receptor, alpha |
| IL2RB | Interleukin 2 receptor, beta |
| IL3 | Interleukin 3 (colony-stimulating factor, multiple) |
| IL31RA | Interleukin 31 receptor A |
| IL4 | Interleukin 4 |
| IL6 | Interleukin 6 (interferon, beta 2) |
| IL7 | Interleukin 7 |
| IL8RB | Interleukin 8 receptor, beta |
| INCA | Inhibitory caspase recruitment domain (CARD) protein |
| ING4 | Inhibitor of growth family, member 4 |
| INHA | Inhibin, alpha |
| INHBA | Inhibin, beta A |
| INPP5D | Inositol polyphosphate-5-phosphatase, 145kDa |
| ITGB2 | Integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| ITGB3BP | Integrin beta 3 binding protein (beta3-endonexin) |
| JAK2 | Janus kinase 2 (a protein tyrosine kinase) |
| JMY | Junction-mediating and regulatory protein |
| KCNIP3 | Kv channel interacting protein 3, calsenilin |
| KIAA1967 | KIAA1967 |
| KNG1 | Kininogen 1 |
| KRT18 | Keratin 18 |
| LAG3 | Lymphocyte-activation gene 3 |
| LALBA | Lactalbumin, alpha- |
| LCK | Lymphocyte-specific protein tyrosine kinase |
| LGALS1 | Lectin, galactoside-binding, soluble, 1 (galectin 1) |
| LGALS12 | Lectin, galactoside-binding, soluble, 12 (galectin 12) |
| LGALS7 | Lectin, galactoside-binding, soluble, 7 (galectin 7) |
| LIG4 | Ligase IV, DNA, ATP-dependent |
| LITAF | Lipopolysaccharide-induced TNF factor |
| LOC653499 | Similar to Galectin-7 (Gal-7) (HKL-14) (PI7) (p53-induced protein 1) |
| LOC730238 | Similar to B-cell receptor-associated protein 31 (BCR-associated protein Bap31) (p28 Bap31) (CDM protein) (6C6-AG tumor-associated antigen) (DXS1357E) |
| LRDD | Leucine-rich repeats and death domain containing |
| LTA | Lymphotoxin alpha (TNF superfamily, member 1) |
| LTBR | Lymphotoxin beta receptor (TNFR superfamily, member 3) |
| LY86 | Lymphocyte antigen 86 |
| MADD | MAP-kinase activating death domain |
| MAEA | Macrophage erythroblast attacher |
| MAGED1 | Melanoma antigen family D, 1 |
| MAGEH1 | Melanoma antigen family H, 1 |
| MAGI3 | Membrane associated guanylate kinase, WW and PDZ domain containing 3 |
| MAL | Mal, T-cell differentiation protein |
| MALT1 | Mucosa associated lymphoid tissue lymphoma translocation gene 1 |
| MAP1S | Microtubule-associated protein 1S |
| MAP3K1 | Mitogen-activated protein kinase kinase kinase 1 |
| MAP3K10 | Mitogen-activated protein kinase kinase kinase 10 |
| MAP3K5 | Mitogen-activated protein kinase kinase kinase 5 |
| MAPK1 | Mitogen-activated protein kinase 1 |
| MAPK8 | Mitogen-activated protein kinase 8 |
| MAPK8IP2 | Mitogen-activated protein kinase 8 interacting protein 2 |
| MAPT | Microtubule-associated protein tau |
| MBD4 | Methyl-CpG binding domain protein 4 |
| MCL1 | Myeloid cell leukemia sequence 1 (BCL2-related) |
| MDM4 | Mdm4, transformed 3T3 cell double minute 4, p53 binding protein (mouse) |
| MGMT | O-6-methylguanine-DNA methyltransferase |
| MIF | Macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
| MKL1 | Megakaryoblastic leukemia (translocation) 1 |
| MMP9 | Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
| MNT | MAX binding protein |
| MOAP1 | Modulator of apoptosis 1 |
| MPO | Myeloperoxidase |
| MRPL41 | Mitochondrial ribosomal protein L41 |
| MRPS30 | Mitochondrial ribosomal protein S30 |
| MSH2 | MutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) |
| MSH6 | MutS homolog 6 (E. coli) |
| MTCH1 | Mitochondrial carrier homolog 1 (C. elegans) |
| MTL5 | Metallothionein-like 5, testis-specific (tesmin) |
| MTP18 | Mitochondrial protein 18 kDa |
| MX1 | Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
| MYBL2 | V-myb myeloblastosis viral oncogene homolog (avian)-like 2 |
| MYC | V-myc myelocytomatosis viral oncogene homolog (avian) |
| MYO18A | Myosin XVIIIA |
| NAIP | NLR family, apoptosis inhibitory protein |
| NCKAP1 | NCK-associated protein 1 |
| NCR1 | Natural cytotoxicity triggering receptor 1 |
| NDUFA13 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 |
| NDUFS1 | NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase) |
| NDUFS3 | NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase) |
| NEK6 | NIMA (never in mitosis gene a)-related kinase 6 |
| NF1 | Neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease) |
| NFKB1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) |
| NFKBIA | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
| NGFR | Nerve growth factor receptor (TNFR superfamily, member 16) |
| NGFR | Nerve growth factor receptor (TNFR superfamily, member 16) |
| NGFRAP1 | Nerve growth factor receptor (TNFRSF16) associated protein 1 |
| NLRC4 | NLR family, CARD domain containing 4 |
| NLRP1 | NLR family, pyrin domain containing 1 |
| NLRP12 | NLR family, pyrin domain containing 12 |
| NLRP2 | NLR family, pyrin domain containing 2 |
| NLRP3 | NLR family, pyrin domain containing 3 |
| NME1 | Non-metastatic cells 1, protein (NM23A) expressed in |
| NME3 | Non-metastatic cells 3, protein expressed in |
| NME5 | Non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase) |
| NME6 | Non-metastatic cells 6, protein expressed in (nucleoside-diphosphate kinase) |
| NOD1 | Nucleotide-binding oligomerization domain containing 1 |
| NOD2 | Nucleotide-binding oligomerization domain containing 2 |
| NOL3 | Nucleolar protein 3 (apoptosis repressor with CARD domain) |
| NOTCH2 | Notch homolog 2 (Drosophila) |
| NOX5 | NADPH oxidase, EF-hand calcium binding domain 5 |
| NPM1 | Nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
| NRG2 | Neuregulin 2 |
| NTF3 | Neurotrophin 3 |
| NTN1 | Netrin 1 |
| NUAK2 | NUAK family, SNF1-like kinase, 2 |
| NUDT2 | Nudix (nucleoside diphosphate linked moiety X)-type motif 2 |
| NUP62 | Nucleoporin 62kDa |
| NUPR1 | Nuclear protein 1 |
| OPA1 | Optic atrophy 1 (autosomal dominant) |
| OSM | Oncostatin M |
| P2RX1 | Purinergic receptor P2X, ligand-gated ion channel, 1 |
| P53AIP1 | P53-regulated apoptosis-inducing protein 1 |
| PACS2 | Phosphofurin acidic cluster sorting protein 2 |
| PAK1 | P21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast) |
| PAK7 | P21(CDKN1A)-activated kinase 7 |
| PAWR | PRKC, apoptosis, WT1, regulator |
| PAX3 | Paired box 3 |
| PAX7 | Paired box 7 |
| PCBP4 | Poly(rC) binding protein 4 |
| PCSK9 | Proprotein convertase subtilisin/kexin type 9 |
| PDCD1 | Programmed cell death 1 |
| PDCD10 | Programmed cell death 10 |
| PDCD11 | Programmed cell death 11 |
| PDCD2 | Programmed cell death 2 |
| PDCD2L | Programmed cell death 2-like |
| PDCD4 | Programmed cell death 4 (neoplastic transformation inhibitor) |
| PDCD5 | Programmed cell death 5 |
| PDCD6 | Programmed cell death 6 |
| PDCD6IP | Programmed cell death 6 interacting protein |
| PDCD7 | Programmed cell death 7 |
| PDCL3 | Phosducin-like 3 |
| PDE1B | Phosphodiesterase 1B, calmodulin-dependent |
| PDIA2 | Protein disulfide isomerase family A, member 2 |
| PDIA3 | Protein disulfide isomerase family A, member 3 |
| PEA15 | Phosphoprotein enriched in astrocytes 15 |
| PECR | Peroxisomal trans-2-enoyl-CoA reductase |
| PEG3 | Paternally expressed 3 |
| PERP | PERP, TP53 apoptosis effector |
| PHB | Prohibitin |
| PHF17 | PHD finger protein 17 |
| PHLDA1 | Pleckstrin homology-like domain, family A, member 1 |
| PHLDA2 | Pleckstrin homology-like domain, family A, member 2 |
| PHLPP | PH domain and leucine rich repeat protein phosphatase |
| PIK3CA | Phosphoinositide-3-kinase, catalytic, alpha polypeptide |
| PIK3CG | Phosphoinositide-3-kinase, catalytic, gamma polypeptide |
| PIK3R2 | Phosphoinositide-3-kinase, regulatory subunit 2 (p85 beta) |
| PIM1 | Pim-1 oncogene |
| PIM2 | Pim-2 oncogene |
| PLAGL1 | Pleiomorphic adenoma gene-like 1 |
| PLAGL2 | Pleiomorphic adenoma gene-like 2 |
| PLEKHF1 | Pleckstrin homology domain containing, family F (with FYVE domain) member 1 |
| PLG | Plasminogen |
| PMAIP1 | Phorbol-12-myristate-13-acetate-induced protein 1 |
| PML | Promyelocytic leukemia |
| POGK | Pogo transposable element with KRAB domain |
| POLB | Polymerase (DNA directed), beta |
| POU4F1 | POU class 4 homeobox 1 |
| POU4F3 | POU class 4 homeobox 3 |
| PPARD | Peroxisome proliferator-activated receptor delta |
| PPM1F | Protein phosphatase 1F (PP2C domain containing) |
| PPP1R13B | Protein phosphatase 1, regulatory (inhibitor) subunit 13B |
| PPP1R13L | Protein phosphatase 1, regulatory (inhibitor) subunit 13 like |
| PPP1R15A | Protein phosphatase 1, regulatory (inhibitor) subunit 15A |
| PPP2CA | Protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform |
| PPP2R1A | Protein phosphatase 2 (formerly 2A), regulatory subunit A , alpha isoform |
| PPP2R1B | Protein phosphatase 2 (formerly 2A), regulatory subunit A, beta isoform |
| PPT1 | Palmitoyl-protein thioesterase 1 (ceroid-lipofuscinosis, neuronal 1, infantile) |
| PRDX2 | Peroxiredoxin 2 |
| PRF1 | Perforin 1 (pore forming protein) |
| PRKAA1 | Protein kinase, AMP-activated, alpha 1 catalytic subunit |
| PRKCA | Protein kinase C, alpha |
| PRKCE | Protein kinase C, epsilon |
| PRKCZ | Protein kinase C, zeta |
| PRKRA | Protein kinase, interferon-inducible double stranded RNA dependent activator |
| PRLR | Prolactin receptor |
| PROC | Protein C (inactivator of coagulation factors Va and VIIIa) |
| PRODH | Proline dehydrogenase (oxidase) 1 |
| PROK2 | Prokineticin 2 |
| PROP1 | PROP paired-like homeobox 1 |
| PRUNE2 | Prune homolog 2 (Drosophila) |
| PSEN1 | Presenilin 1 (Alzheimer disease 3) |
| PSEN2 | Presenilin 2 (Alzheimer disease 4) |
| PTEN | Phosphatase and tensin homolog (mutated in multiple advanced cancers 1) |
| PTH | Parathyroid hormone |
| PTK2B | PTK2B protein tyrosine kinase 2 beta |
| PTPN6 | Protein tyrosine phosphatase, non-receptor type 6 |
| PTPRC | Protein tyrosine phosphatase, receptor type, C |
| PTRH2 | Peptidyl-tRNA hydrolase 2 |
| PYCARD | PYD and CARD domain containing |
| RAB27A | RAB27A, member RAS oncogene family |
| RABEP1 | Rabaptin, RAB GTPase binding effector protein 1 |
| RAD21 | RAD21 homolog (S. pombe) |
| RAD9A | RAD9 homolog A (S. pombe) |
| RAF1 | V-raf-1 murine leukemia viral oncogene homolog 1 |
| RARG | Retinoic acid receptor, gamma |
| RASA1 | RAS p21 protein activator (GTPase activating protein) 1 |
| RASSF5 | Ras association (RalGDS/AF-6) domain family 5 |
| RBED1 | RNA binding motif and ELMO/CED-12 domain 1 |
| RELA | V-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian) |
| RFFL | Ring finger and FYVE-like domain containing 1 |
| RHOB | Ras homolog gene family, member B |
| RHOT1 | Ras homolog gene family, member T1 |
| RHOT2 | Ras homolog gene family, member T2 |
| RIPK1 | Receptor (TNFRSF)-interacting serine-threonine kinase 1 |
| RIPK2 | Receptor-interacting serine-threonine kinase 2 |
| RIPK3 | Receptor-inte |